Business context and reporting period
The supplied filing is Dr Pepper Snapple Group, Inc.’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2013—not a filing under the name Keurig Dr Pepper Inc. The company operated beverage-concentrate, packaged-beverage and Latin America beverage businesses.
Financial performance and liquidity
| Metric | Q3 2013 | Nine months 2013 |
|---|---|---|
| Net sales | $1.543 billion, up 1% | $4.534 billion, up 1% |
| Gross profit / margin | $893 million / 57.9% (59.0% prior year) | $2.618 billion / 57.7% (58.0% prior year) |
| Operating income / margin | $300 million / 19.4% (down from $308 million / 20.1%) | $782 million / 17.2% (down from $800 million / 17.7%) |
| Net income | $207 million, versus $179 million | $468 million, versus $459 million |
| Diluted EPS | $1.01, versus $0.84 | $2.28, versus $2.15 |
| Operating cash flow | Not presented for the quarter | $616 million, versus $282 million |
At September 30, cash was $119 million; current assets were $1.059 billion and current liabilities $956 million. Long-term obligations were $2.521 billion, with $1 million current. The company had no commercial paper or revolver borrowings and reported $498 million available under its $500 million revolving facility; it was in covenant compliance. Nine-month capital expenditures were $111 million. Financing used $732 million, including $243 million of share repurchases, $225 million of dividends and repayment of $250 million of notes.
Material changes versus prior comparable periods
- Q3 volume (bottler case sales) was flat; nine-month volume declined 2%. Pricing and mix supported sales despite weaker volume.
- Q3 gross margin fell 1.1 percentage points. Management cited commodity costs, unfavorable product and package mix, and a $15 million unfavorable year-over-year comparison in commodity-derivative mark-to-market results; favorable LIFO comparisons and productivity partly offset these pressures.
- For nine months, operating income declined 2% as higher SG&A and unallocated corporate costs more than offset slightly higher gross profit. Segment operating profit rose in all three segments, while corporate costs increased.
- Operating cash flow increased from the prior-year period, primarily because 2012 included $531 million of tax payments related to licensing agreements. Working-capital comparisons were unfavorable. The filing corrected 2012 cash-flow figures: operating cash flow increased from $264 million to $282 million and capital expenditures from $143 million to $161 million.
Outlook, commentary, risks and unusual items
- Management expected 2013 capital expenditures, net of disposals, of approximately 3% of net sales and said operating cash flows should meet anticipated obligations over the next 12 months. No specific earnings or revenue guidance was provided.
- A completed IRS audit of 2006–2008 returns led to a $463 million tax benefit, primarily from reducing unrecognized tax benefits, and a $430 million expense because the company no longer expected to collect related indemnification from Mondelēz. Management said the net noncash effect increased Q3 net income by $33 million, or diluted EPS by $0.16. Reported earnings growth therefore includes a significant unusual item.
- A Canadian tax-law change produced $38 million of indemnity income and $50 million of tax expense during the nine-month period. Commodity prices, foreign exchange, consumer demand, seasonality, and the ability to pass on costs remain relevant risks. Management estimated a 10% currency move could change annual operating income by about $16 million; unhedged commodity-price movements could affect remaining-2013 operating income by about $2 million.
- The company reported a $12 million reserve at quarter-end for the Ward age-discrimination litigation after settling with five plaintiffs. A New Jersey Superfund matter remained unquantified; the filing said no reasonable loss estimate was available. Management did not expect pending legal matters, individually or collectively, to materially adversely affect results, financial condition or liquidity.
- Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter. It reported no material changes to the prior annual report’s risk factors.
Important facts for investors to verify
- Confirm issuer identity and period: the source is Dr Pepper Snapple Group’s 2013 Q3 10-Q, not a Keurig Dr Pepper filing.
- Assess earnings excluding the IRS audit and Mondelēz indemnity effects, and distinguish reported from underlying tax rates and EPS.
- Review volume trends, especially declines in U.S. and Canadian beverage categories, against pricing, product mix and segment profitability.
- Track commodity and LIFO effects on margins, cash conversion, working capital, and the company’s planned capital spending and shareholder distributions.
- Monitor liquidity and debt maturities, including the concentration of cash held in foreign operations, covenant compliance and available borrowing capacity.
- Revisit litigation, environmental matters, and multiemployer pension withdrawal exposure as estimates or developments become available.